Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02958215Phase 2Completed
Phase 2, randomised trial in hypotension comparing Placebo Group with Phenylephrine Group (2 arms). Primary endpoint: Incidence of hypotension at 24 hours. Started Jun 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02958215.